References
- Albert, M. L., Goodglass, H., Helm, N. A., Rubens, A. B., & Alexander, M. P. (1981). Clinical aspect of dysphasia. In G. E. Arnold, F. Winckel, & B. D. Wyle (Eds.), Disorders of human communication 2. Springer-Verlag Wien.
- Albert, M. L. (1998). Treatment of aphasia. Archives of Neurology, 55(11), 1417–1419. https://doi.org/10.1001/archneur.55.11.1417
- Albert, M. L., Bachman, D. L., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy for aphasia. Neurology, 38(6), 877–879. https://doi.org/10.1212/WNL.38.6.877
- Alexander, M. P. (2006). Impairments of procedures for implementing complex language are due to disruption of frontal attention processes. Journal of the International Neuropsychological Society, 12(2), 236–247. https://doi.org/10.1017/S1355617706060309
- Allen, L., Mehta, S., McClure, J. A., & Teasell, R. (2012). Therapeutic interventions for aphasia initiated more than six months post stroke: A review of the evidence. Topics in Stroke Rehabilitation, 19(6), 523–535. https://doi.org/10.1310/tsr1906-523
- Altieri, M., Di Piero, V., & Lenzi, G. L. Drugs and recovery: A challenge for a few? (2002). Stroke, 33(4), 1170. (letter). https://doi.org/10.1161/01.STR.0000012265.78381.ED
- Amaducci, L., Sorbi, S., Albanese, A., & Gainotti, G. (1981). Choline acetyltransferase (CHAT) activity differs in right and left human temporal lobes. Neurology, 31(7), 799–805. https://doi.org/10.1212/WNL.31.7.799
- Amunts, K., Lenzen, M., Friederici, A. D., Schleicher, A., Morosan, P., Palomero-Gallagher, N., Poeppel, D., & Zilles, K. (2010). Broca’s region: Novel organizational principles and multiple receptor mapping. PLoS Biology, 8(9), e1000489. https://doi.org/10.1371/journal.pbio.1000489
- Antal, A., Alekseichuk, I., Bikson, M., Brockmöller, J., Brunoni, A. R., Chen, R., Cohen, L. G., Dowthwaite, G., Ellrich, J., Flöel, A., Fregni, F., George, M. S., Hamilton, R., Haueisen, J., Herrmann, C. S., Hummel, F. C., Lefaucheur, J. P., Liebetanz, D., Loo, C. K., Miniussi, C., … Paulus, W. (2017). Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clinical Neurophysiology, 128(9), 1774–1809. https://doi.org/10.1016/j.clinph.2017.06.001
- Asadollahi, M., Ramezan, M., Khanmoradi, Z., & Karimialavijeh, E. (2018). The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: A double-blind placebo-controlled randomized controlled trial. Clinical Rehabilitation, 32(8), 1069–1075. https://doi.org/10.1177/0269215518777791
- Ashtary, F., Janghorbani, M., Chitsaz, A., Reisi, M., & Bahrami, A. (2006). A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology, 66(6), 914–916. https://doi.org/10.1212/01.wnl.0000203119.91762.0c
- Bae, H., Park, J., & Yang, Y. (2019). Improvement of post stroke echolalia after using selective serotonin reuptake inhibitors. Dementia and Neurocognitive Disorders, 18(1), 30–32. https://doi.org/10.12779/dnd.2019.18.1.30
- Bakheit, A. M. O. (2004). Drug treatment of post-stroke aphasia. Expert Review in Neurotherapeutics, 4(2), 211–217. https://doi.org/10.1586/14737175.4.2.211
- Barbancho, M. A., Berthier, M. L., Navas-Sánchez, P., Dávila, G., Green-Heredia, C., García-Alberca, J. M., Ruiz-Cruces, R., López-González, M. V., Dawid-Milner, M. S., Pulvermüller, F., & Lara, J. P. (2015). Bilateral brain reorganization with memantine and constraint-induced aphasia therapy in chronic post-stroke aphasia: An ERP study. Brain and Language, 145–146, 1–10. https://doi.org/10.1016/j.bandl.2015.04.003
- Barrett, K. M., Brott, T. G., Brown, R. D., Carter, R. E., Geske, J. R., Graff-Radford, N. R., McNeil, R. B., & Meschia, J. F., & Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) Study Group. (2011). Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: Results of a phase IIA clinical trial. Journal of Stroke and Cerebrovascular Diseases, 20(3), 177–182. https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.12.009
- Basso, A., & Macis, M. (2011). Therapy efficacy in chronic aphasia. Behavioural Neurology, 24(4), 317–325. https://doi.org/10.1155/2011/313480
- Berthier, M. L. (2005). Poststroke aphasia: Epidemiology, pathophysiology and treatment. Drugs & Aging, 22(2), 163–182. https://doi.org/10.2165/00002512-200522020-00006
- Berthier, M. L. (2014). Cognitive enhancing drugs in aphasia: A vote for hope. Aphasiology, 28(2), 128–132. https://doi.org/10.1080/02687038.2013.857756
- Berthier, M. L., Dávila, G., & Torres-Prioris, M. J. (2015). Neuropharmacologic approaches to aphasia rehabilitation. In R. H. Bahr & E. R. Silliman (Eds.), Routledge handbook of communication disorders (pp. 90–99). Routledge Taylor & Francis Group.
- Berthier, M. L., Dávila, G., Edelkraut, L., López-Barroso, D., Torres-Prioris, M. J., & Tubio, J. (2020). Pharmacological treatment of post-stroke cognitive deficits. In R. M. Lazar, M. Pavol, & J. Browndyke (Eds.), Neurovascular neuropsychology (2nd ed.). Springer Science + Business Media. Behavioral Sciences.
- Berthier, M. L., Dávila, G., Green, C., Moreno-Torres, I., Juárez Y Ruiz de Mier, R., De-Torres, I., … Ruiz-Cruces, R. (2014). Massed sentence repetition tr aining can augment and speed up recovery of speech production deficits in patients with chronic conduction aphasia receiving donepezil treatment. Aphasiology, 28(2), 188–218. https://doi.org/10.1080/02687038.2013.861057
- Berthier, M. L., De-Torres, I., Paredes-Pacheco, J., Roé-Vellvé, N., Thurnhofer-Hemsi, K., Torres-Prioris, M. J., Alfaro, F., Moreno-Torres, I., López-Barroso, D., & Dávila, G. (2017). Cholinergic potentiation and audiovisual repetition-imitation therapy improve speech production and communication deficits in a person with crossed aphasia by inducing structural plasticity in white matter tracts. Frontiers in Human Neuroscience, 11, 304. https://doi.org/10.3389/fnhum.2017.00304
- Berthier, M. L., García-Casares, N., Walsh, S. F., Nabrozidis, A., Ruíz de Mier, R. J., Green, C., Dávila, G., Gutiérrez, A., & Pulvermüller, F. (2011). Recovery from post-stroke aphasia: Lessons from brain imaging and implications for rehabilitation and biological treatments. Discovery Medicine, 12(65), 275–289. ISSN: 1539-6509.
- Berthier, M. L., Green, C., Higueras, C., Fernández, I., Hinojosa, J., & Martín, M. C. (2006). A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology, 67(9), 1687–1689. https://doi.org/10.1212/01.wnl.0000242626.69666.e2
- Berthier, M. L., Green, C., Lara, J. P., Higueras, C., Barbancho, M. A., Dávila, G., & Pulvermüller, F. (2009). Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Annals of Neurology, 65(5), 577–585. https://doi.org/10.1002/ana.21597
- Berthier, M. L., Hinojosa, J., Martín, Mdel C, & Fernández, I. (2003). Open-label study of donepezil in chronic poststroke aphasia. Neurology, 60(7), 1218–1219. https://doi.org/10.1212/01.WNL.0000055871.82308.41
- Berthier, M. L., & Pulvermüller, F. (2011). Neuroscience insights improve neurorehabilitation of poststroke aphasia. Nature Reviews. Neurology, 7(2), 86–97. https://doi.org/10.1038/nrneurol.2010.201
- Berthier, M. L., Pulvermüller, F., Dávila, G., Casares, N. G., & Gutiérrez, A. (2011). Drug therapy of post-stroke aphasia: A review of current evidence. Neuropsychology Review, 21(3), 302–317. https://doi.org/10.1007/s11065-011-9177-7
- Berthier, M. L., Torres-Prioris, M. J., López-Barroso, D., Thurnhofer-Hemsi, K., Paredes-Pacheco, J., Roé-Vellvé, N., Alfaro, F., Pertierra, L., & Dávila, G. (2017). Are you a doctor? … Are you a doctor? I’m not a doctor! A reappraisal of mitigated echolalia in aphasia with evaluation of neural correlates and treatment approaches. Aphasiology, 32(7), 784–813. https://doi.org/10.1080/02687038.2016.1274875
- Berube, S., & Hillis, A. E. (2019). Advances and innovations in aphasia treatment trials. Stroke, 50(10), 2977–2984. https://doi.org/10.1161/STROKEAHA.119.025290
- Beversdorf, D. Q., Sharma, U. K., Phillips, N. N., Notestine, M. A., Slivka, A. P., Friedman, N. M., Schneider, S. L., Nagaraja, H. N., & Hillier, A. (2007). Effect of propranolol on naming in chronic Broca’s, aphasia with anomia. Neurocase, 13(4), 256–259. https://doi.org/10.1080/13554790701595471
- Biou, E., Cassoudesalle, H., Cogné, M., Sibon, I., De Gabory, I., Dehail, P., Aupy, J., & Glize, B. (2019). Transcranial direct current stimulation in post-stroke aphasia rehabilitation: A systematic review. Annals of Physical and Rehabilitation Medicine, 62(2), 104–121. https://doi.org/10.1016/j.rehab.2019.01.003
- Blundo, C., & Gerace, C. (2015). Dopamine agonists can improve pure apathy associated with lesions of the prefrontal-basal ganglia functional system. Neurological Sciences, 36(7), 1197–1201. https://doi.org/10.1007/s10072-014-2061-5
- Bohnen, N. I., Bogan, C. W., & Müller, M. L. (2009). Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections. European Neurological Journal, 1(1), 33–50. PMCID: PMC3387993.
- Boyd, L. A., Hayward, K. S., Ward, N. S., Stinear, C. M., Rosso, C., Fisher, R. J., Carter, A. R., Leff, A. P., Copland, D. A., Carey, L. M., Cohen, L. G., Basso, D. M., Maguire, J. M., & Cramer, S. C. (2017). Biomarkers of stroke recovery: Consensus-based core recommendations from the stroke recovery and rehabilitation roundtable. Neurorehabilitation and Neural Repair, 31(10–11), 864–876. https://doi.org/10.1177/1545968317732680
- Braida, D., Paladini, E., Griffini, P., Lamperti, M., Maggi, A., & Sala, M. (1996). An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: Comparison with other cholinesterase inhibitors. European Journal of Pharmacology, 302(1–3), 13–20. https://doi.org/10.1016/0014-2999(96)00072-6
- Breitenstein, C., Grewe, T., Flöel, A., Ziegler, W., Springer, L., Martus, P., Huber, W., Willmes, K., Ringelstein, E. B., Haeusler, K. G., Abel, S., Glindemann, R., Domahs, F., Regenbrecht, F., Schlenck, K.-J., Thomas, M., Obrig, H., de Langen, E., Rocker, R., Wigbers, F., & Bamborschke, S., & FCET2EC study group. (2017). Intensive speech and language therapy in patients with chronic aphasia after stroke: A randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. The Lancet, 389(10078), 1528–1538. https://doi.org/10.1016/S0140-6736(17)30067-3
- Breitenstein, C., Korsukewitz, C., Baumgärtner, A., Flöel, A., Zwitserlood, P., Dobel, C., … Knecht, S. (2015). L-dopa does not add to the success of high-intensity language training in aphasia. Restorative Neurology and Neuroscience, 33(2), 115–120. https://doi.org/10.3233/RNN-140435
- Buckingham, H. W., & Buckingham, S. S. (2011). Is recurrent perseveration a product of deafferented functional systems with otherwise normal post-activation decay rates? Clinical Linguistics & Phonetics, 25(11–12), 1066–1073. https://doi.org/10.3109/02699206.2011.616982
- Cahana-Amitay, D., Albert, M. L., & Oveis, A. (2014). Psycholinguistics of aphasia pharmacotherapy: Asking the right questions. Aphasiology, 28(2), 133–154. https://doi.org/10.1080/02687038.2013.818099
- Cahana-Amitay, D., Oveis, A. C., Sayers, J. T., Pineles, S. L., Spiro, A., 3rd, & Albert, M. L. (2015). Biomarkers of “Linguistic Anxiety” in aphasia: A proof-of-concept case study. Clinical Linguistics & Phonetics, 29(5), 401–413. https://doi.org/10.3109/02699206.2015.1014572
- Cappa, S. F., Ortelli, P., Garibotto, V., & Zamboni, M. (2007). Reversible nonfluent aphasia and left frontal hypoperfusion during topiramate treatment. Epilepsy & Behavior, 10(1), 192–194. https://doi.org/10.1016/j.yebeh.2006.11.001
- Caspers, S., Schleicher, A., Bacha-Trams, M., Palomero-Gallagher, N., Amunts, K., & Zilles, K. (2013). Organization of the human inferior parietal lobule based on receptor architectonics. Cerebral Cortex, 23(3), 615–628. https://doi.org/10.1093/cercor/bhs048
- Chen, Y., Li, Y.-S, Wang, Z.-Y, Xu, Q., Shi, G.-W, & Lin, Y. (2010). The efficacy of donepezil for post-stroke aphasia: A pilot case control study. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine], 49(2), 115–118. doi:10.1159/000444253
- Chen, Y.-D, Zhang, J., Wang, Y., Yuan, J.-L, & Hu, W.-L. (2016). Efficacy of cholinesterase inhibitors in vascular dementia: An updated meta-analysis. European Neurology, 75(3–4), 132–141. https://doi.org/10.1159/000444253
- Chollet, F., Tardy, J., Albucher, J., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., & Loubinoux, I. (2011). Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial. The Lancet Neurology, 10(2), 123–130. https://doi.org/10.1016/S1474-4422(10)70314-8
- Chuah, L. Y., & Chee, M. W. (2008). Cholinergic augmentation modulates visual task performance in sleep-deprived young adults. Journal of Neuroscience, 28(44), 11369–11377. https://doi.org/10.1523/JNEUROSCI.4045-08.2008
- Chuah, L. Y., Chong, D. L., Chen, A. K., Rekshan, W. R., Tan, J.-C, Zheng, H., … Chee, M. W. (2009). Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation. Sleep, 32(8), 999–1010. https://doi.org/10.1093/sleep/32.8.999
- Cicerone, K. D., Goldin, Y., Ganci, K., Rosenbaum, A., Wethe, J. V., Langenbahn, D. M., Malec, J. F., Bergquist, T. F., Kingsley, K., Nagele, D., Trexler, L., Fraas, M., Bogdanova, Y., & Harley, J. P. (2019). Evidence-based cognitive rehabilitation: Systematic review of the literature from 2009 through 2014. Archives of Physical Medicine and Rehabilitation, 100(8), 1515–1533. https://doi.org/10.1016/j.apmr.2019.02.011
- Clout, A. E., Della Pasqua, O., Hanna, M. G., Orlu, M., & Pitceathly, R. D. S. (2019). Drug repurposing in neurological diseases: An integrated approach to reduce trial and error. Journal of Neurology, Neurosurgery, and Psychiatry, 90(11), 1270–1275. https://doi.org/10.1136/jnnp-2019-320879
- Code, C., Papathanasiou, I., Rubio-Bruno, S., de la Paz Cabana, M., Villanueva, M. M., Haaland-Johansen, L., Prizl-Jakovac, T., Leko, A., Zemva, N., Patterson, R., Berry, R., Rochon, E., Leonard, C., & Robert, A. (2016). International patterns of the public awareness of aphasia. International Journal of Language & Communication Disorders, 51(3), 276–284. https://doi.org/10.1111/1460-6984.12204
- Code, C., & Petheram, B. (2011). Delivering for aphasia. International Journal of Speech and Language Pathology, 13(1), 3–10. https://doi.org/10.3109/17549507.2010.520090
- Code, C., Torney, A., Gildea-Howardine, E., & Willmes, K. (2010). Outcome of a one-month therapy intensive for chronic aphasia: Variable individual responses. Seminars in Speech and Language, 31(1), 21–33. https://doi.org/10.1055/s-0029-1244950
- Cohen, L., Chaaban, B., & Habert, M. O. (2004). Transient improvement of aphasia with zolpidem. New England Journal of Medicine, 350(9), 949–950. https://doi.org/10.1056/NEJM200402263500922
- Conroy, P., Sotiropoulou Drosopoulou, C., Humphreys, G. F., Halai, A. D., & Lambon Ralph, M. A. (2017). Time for a quick word? The striking benefits of training speed and accuracy of word retrieval in post-stroke aphasia. Brain, 141(6), eds1815–eds1827. https://doi.org/10.1093/brain/awy087
- Cramer, S. C. (2008). Repairing the human brain after stroke. II. Restorative therapies. Annals of Neurology, 63(5), 549–560. https://doi.org/10.1002/ana.21412
- Cramer, S. C. (2018). Treatments to promote neural repair after stroke. Journal of Stroke, 20(1), 57–70. https://doi.org/10.5853/jos.2017.02796
- Cramer, S. C., Koroshetz, W. J., & Finklestein, S. P. (2007). The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke, 38(4), 1393–1395. https://doi.org/10.1161/01.STR.0000260087.67462.80
- Cramer, S. C., Sur, M., Dobkin, B. H., O’Brien, C., Sanger, T. D., Trojanowski, J. Q., Rumsey, J. M., Hicks, R., Cameron, J., Chen, D., Chen, W. G., Cohen, L. G., deCharms, C., Duffy, C. J., Eden, G. F., Fetz, E. E., Filart, R., Freund, M., Grant, S. J., Kalivas, P. W., … Vinogradov, S. (2011). Harnessing neuroplasticity for clinical applications. Brain, 134(6), 1591–1609. https://doi.org/10.1093/brain/awr039
- Cravello, L., Caltagirone, C., & Spalletta, G. (2009). The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression. Human Psychopharmacology: Clinical and Experimental, 24(4), 331–336. https://doi.org/10.1002/hup.1021
- Crosson, B., Rodriguez, A. D., Copland, D., Fridriksson, J., Krishnamurthy, L. C., Meinzer, M., … Leff, A. P. (2019, May 4). Neuroplasticity and aphasia treatments: New approaches for an old problem. Journal of Neurology, Neurosurgery, and Psychiatry, jnnp-2018-319649, 90(10), 1147-1155. 1136/jnnp-2018-319649
- De Dyen, P., De Reuck, J. D., Deberdt, W., Vlietinck, R., & Orgogozo, J.-M., & Members of the Piracetam in Acute Stroke Study (PASS) Group. (1997). Treatment of acute ischaemic stroke with piracetam. Stroke, 28(12), 2347–2352. https://doi.org/10.1161/01.STR.28.12.2347
- de la Vega, A., Brown, M. S., Snyder, H. R., Singel, D., Munakata, Y., & Banich, M. T. (2014). Individual differences in the balance of GABA to glutamate in pFC predict the ability to select among competing options. Journal of Cognitive Neuroscience, 26(11), 2490–2502. https://doi.org/10.1162/jocn_a_00655
- Difrancesco, S., Pulvermüller, F., & Mohr, B. (2012). Intensive language-action therapy (ILAT): The methods. Aphasiology, 26(11), 1317–1351. https://doi.org/10.1080/02687038.2012.705815
- Dignam, J., Copland, D., McKinnon, E., Burfein, P., O’Brien, K., Farrell, A., … Rodriguez, A. D. (2015). Intensive versus distributed aphasia therapy: A nonrandomized, parallel-group, dosage-controlled study. Stroke, 46(8), 2206–2211. doi:10.1161/STROKEAHA.115.009522
- Dignam, J. K., Rodriguez, A. D., & Copland, D. A. (2016). Evidence for intensive aphasia therapy: Consideration of theories from neuroscience and cognitive psychology. PM R. The Journal of Injury, Function, and Rehabilitation, 8(3), 254–267. https://doi.org/10.1016/j.pmrj.2015.06.010
- Doogan, C., Dignam, J., Copland, D., & Leff, A. (2018). Aphasia recovery: When, how and who to treat? Current Neurology and Neuroscience Reports, 18(12), 90. https://doi.org/10.1007/s11910-018-0891-x
- El Hachioui, H., Visch-Brink, E. G., Lingsma, H. F., van de Sandt-koenderman, M. W., Dippel, D. W., Koudstaal, P. J., & Middelkoop, H. A. (2014). Nonlinguistic cognitive impairment in poststroke aphasia: A prospective study. Neurorehabilitation and Neural Repair, 28(3), 273–281. https://doi.org/10.1177/1545968313508467
- Elman, R. J., Ogar, J., & Elman, S. (2000). Aphasia: Awareness, advocacy, and activism. Aphasiology, 14(5/6), 455–459. https://doi.org/10.1080/026870300401234
- Elsner, B., Kugler, J., Pohl, M., & Mehrholz, J. (2019, May 21). Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke. The Cochrane Database of Systematic Reviews, 5, CD009760. doi:10.1002/14651858.CD009760.pub4
- Enderby, P., Broeckx, J., Hospers, W., Schildermans, F., & Deberdt, W. (1994). Effect of piracetam on recovery and rehabilitation after stroke: A double-blind, placebo-controlled study. Clinical Neuropharmacology, 17(4), 320–331. https://doi.org/10.1097/00002826-199408000-00003
- Engelter, S. T., Urscheler, N., Baronti, F., Vuadens, P., Koch, J., Frank, M., Jenni, W., & Disserens, K. (2012). Frequency and determinants of using pharmacological enhancement in the clinical practice of in-hospital stroke rehabilitation. European Neurology, 68(1), 28–33. https://doi.org/10.1159/000335895
- Faingold, C. L., & Blumenfeld, H. (2015). Targeting neuronal networks with combined drug and stimulation paradigms guided by neuroimaging to treat brain disorders. The Neuroscientist, 21(5), 460–474. https://doi.org/10.1177/1073858415592377
- Falchook, A. D., Heilman, K. M., Finney, G. R., Gonzalez-Rothi, L. J., & Nadeau, S. E. (2014). Neuroplasticity, neurotransmitters and new directions for treatment of anomia in Alzheimer’s disease. Aphasiology, 28(2), 219–235. https://doi.org/10.1080/02687038.2013.793283
- Farooq, M. U., Min, J., Goshgarian, C., & Gorelick, P. B. (2017). Pharmacotherapy for vascular cognitive impairment. CNS Drugs, 31(9), 759–776. https://doi.org/10.1007/s40263-017-0459-3
- Fedorenko, E., Duncan, J., & Kanwisher, N. (2012). Language-selective and domain-general regions lie side by side within broca’s area. Current Biology, 22(21), 2059–2062. https://doi.org/10.1016/j.cub.2012.09.011
- Firth, N., Barker, R. N., Hayward, K. S., Bernhardt, J., Bellingan, M., & Gunnarsson, R. (2019). Safety and efficacy of recovery-promoting drugs for motor function after stroke: A systematic review of randomized controlled trials. Journal of Rehabilitation Medicine, 51(5), 319–330. https://doi.org/10.2340/16501977-2536
- Floel, A., & Cohen, L. G. (2010). Recovery of function in humans: Cortical stimulation and pharmacological treatments after stroke. Neurobiology of Disease, 37(2), 243–251. https://doi.org/10.1016/j.nbd.2009.05.027
- Franklin, S., Harhen, D., Hayes, M., Mc Manus, S., & Pollock, A. (2018). Top 10 research priorities relating to aphasia following stroke. Aphasiology, 32(11), 1388–1395. https://doi.org/10.1080/02687038.2017.1417539
- Fridriksson, J. (2011). Measuring and inducing brain plasticity in chronic aphasia. Journal of Communicative Disorders, 44(5), 557–563. doi: 10.1016/j.jcomdis.2011.04.009
- Fridriksson, J., Elm, J., Stark, B. C., Basilakos, A., Rorden, C., Sen, S., George, M. S., Gottfried, M., & Bonilha, L. (2018). BDNF genotype and tDCS interaction in aphasia treatment. Brain Stimulation, 11(6), 1276–1281. https://doi.org/10.1016/j.brs.2018.08.009
- Fridriksson, J., Rorden, C., Elm, J., Sen, S., George, M. S., & Bonilha, L. (2018). Transcranial direct current stimulation vs sham stimulation to treat aphasia after stroke: A randomized clinical trial. JAMA Neurology, 75(12), 1470–1476. https://doi.org/10.1001/jamaneurol.2018.2287
- Furey, M. L. (2011). The prominent role of stimulus processing: Cholinergic function and dysfunction in cognition. Current Opinion in Neurology, 24(4), 364–370. https://doi.org/10.1097/WCO.0b013e328348bda5
- Galling, M. A., Goorah, H., Berthier, M. L., & Sage, K. (2014). A clinical study of the combined use of bromocriptine and speech and language therapy in the treatment of a person with aphasia. Aphasiology, 28(2), 171–187. https://doi.org/10.1080/02687038.2013.838616
- García, R. R., Montiel, J. F., Villalón, A. U., Gatica, M. A., & Aboitiz, F. (2004). AChE-rich magnopyramidal neurons have a left+right size asymmetry in Broca’s area. Brain Research, 1026(2), 313–316. https://doi.org/10.1016/j.brainres.2004.08.050
- Geranmayeh, F., Brownsett, S. L., & Wise, R. J. (2014). Task-induced brain activity in aphasic stroke patients: What is driving recovery? Brain, 137(10), 2632–2648. https://doi.org/10.1093/brain/awu163
- Geranmayeh, F., Chau, T. W., Wise, R. J. S., Leech, R., & Hampshire, A. (2017). Domain-general subregions of the medial prefrontal cortex contribute to recovery of language after stroke. Brain, 140(7), 1947–1958. https://doi.org/10.1093/brain/awx134
- Gill, S. K., & Leff, A. P. (2014). Dopaminergic therapy in aphasia. Aphasiology, 28(2), 155–170. https://doi.org/10.1080/02687038.2013.802286
- Goldstein, L. B. (1995). Common drugs may influence motor recovery after stroke: The sygen in acute stroke study investigations. Neurology, 45(5), 865–871. https://doi.org/10.1212/WNL.45.5.865
- Goldstein, L. B. (1998). Potential effects of common drugs on stroke recovery. Archives of Neurology, 55(4), 454–456. https://doi.org/10.1001/archneur.55.4.454
- Gordon, J. (1994). Speechless: My recovery from stroke. University of Western Australia Press Nedlands.
- Gorgoraptis, N., Mah, Y.-H, Machner, B., Singh-Curry, V., Malhotra, P., Hadji-Michael, M., Cohen, D., Simister, R., Nair, A., Kulinskaya, E., Ward, N., Greenwood, R., & Husain, M. (2012). The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke. Brain, 135(8), 2478–2491. https://doi.org/10.1093/brain/aws154
- Greener, J., Enderby, P., & Whurr, R. (2001). Pharmacological treatment for aphasia following stroke. The Cochrane Database Systematic Reviews, 4, CD000424. doi:10.1002/14651858.CD000424
- Gu, Z., Alexander, G. M., Dudek, S. M., & Yakel, J. L. (2017). Hippocampus and entorhinal cortex recruit cholinergic and NMDA receptors separately to generate hippocampal theta oscillations. Cell Reports, 21(12), 3585–3595. https://doi.org/10.1016/j.celrep.2017.11.080
- Güngör, L., Terzi, M., & Onar, M. K. (2011). Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases? Brain and Language, 117(1), 23–27. https://doi.org/10.1016/j.bandl.2010.11.003
- Gupta, S. R., Mlcoch, A. G., Scolaro, C., & Moritz, T. (1995). Bromocriptine treatment of nonfluent aphasia. Neurology, 45(12), 2170–2173. doi:10.1212/wnl.45.12.2170
- Hartwigsen, G. (2018). Flexible redistribution in cognitive networks. Trends in Cognitive Science, 22(8), 687–698. doi:10.1016/j.tics.2018.05.008
- Heikkinen, P. H., Pulvermüller, F., Mäkelä, J. P., Ilmoniemi, R. J., Lioumis, P., Kujala, T., Manninen, R.-L., Ahvenainen, A., & Klippi, A. (2019). Combining rTMS with intensive language-action therapy in chronic aphasia: A randomized controlled trial. Frontiers in Neuroscience, 12, 1036. https://doi.org/10.3389/fnins.2018.01036
- Hill, A., Blevins, R., & Code, C. (2018). Revisiting the public awareness of aphasia in exeter: 16 years on. International Journal of Speech and Language Pathology, 11, 1–10. doi:10.1080/17549507.2018.1485742
- Hillis, A. E., Beh, Y. Y., Sebastian, R., Breining, B., Tippett, D. C., Wright, A., Saxena, S., Rorden, C., Bonilha, L., Basilakos, A., Yourganov, G., & Fridriksson, J. (2018). Predicting recovery in acute poststroke aphasia. Annals of Neurology, 83(3), 612–622. https://doi.org/10.1002/ana.25184
- Hong, J. M., Shin, D. H., Lim, T. S., Lee, J. S., & Huh, K. (2012). Galantamine administration in chronic post-stroke aphasia. Journal of Neurology, Neurosurgery, and Psychiatry, 83(7), 675–680. https://doi.org/10.1136/jnnp-2012-302268
- Huang, J., Liu, X., Luo, X., Tang, C., Xu, M., Wood, L., Wang, Y., Wang, Y., & Wang, Q. M. (2018). Effects of fluoxetine on poststroke dysphagia: A clinical retrospective study. Journal of Stroke and Cerebrovascular Diseases, 27(11), 3320–3327. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.07.034
- Huber, R., Ghilardi, M. F., Massimini, M., & Tononi, G. (2004). Local sleep and learning. Nature, 430(6995), 78–81. https://doi.org/10.1038/nature02663
- Huber, W., Willmes, K., Poeck, K., Van Vleymen, B., & Deberdt, W. (1997). Piracetam as an adjuvant to language therapy for aphasia: A randomized double-blind placebo-controlled pilot study. Archives of Physical Medicine and Rehabilitation, 78(3), 245–250. https://doi.org/10.1016/S0003-9993(97)90028-9
- Huerta-Ocampo, I., Hacioglu-Bay, H., Dautan, D., & Mena-Segovia, J. (2020). Distribution of midbrain cholinergic axons in the thalamus. eNeuro, 7(1), ENEURO.0454–19.2019. https://doi.org/10.1523/ENEURO.0454-19.2019
- Hughes, J. D., Jacobs, D. H., & Heilman, K. M. (2000). Neuropharmacology and linguistic neuroplasticity. Brain and Language, 71(1), 96–101. https://doi.org/10.1006/brln.1999.2223
- Husain, M., & Mehta, M. A. (2011). Cognitive enhancement by drugs in health and disease. Trends in Cognitive Science, 15(1), 28–36. https://doi.org/10.1016/j.tics.2010.11.002
- Hutsler, J. J., & Gazzaniga, M. S. (1996). Acetylcholinesterase staining in human auditory and language cortices: Regional variation of structural features. Cerebral Cortex, 6(2), 260–270. https://doi.org/10.1093/cercor/6.2.260
- Imamura, O., Arai, M., Dateki, M., Ogata, T., Uchida, R., Tomoda, H., & Takishima, K. (2015). Nicotinic acetylcholine receptors mediate donepezil-induced oligodendrocyte differentiation. Journal of Neurochemistry, 135(6), 1086–1098. https://doi.org/10.1111/jnc.13294
- Jianu, D. C., Muresanu, D. F., Bajenaru, O., Popescu, B. O., Deme, S. M., Moessler, H., … Petrica, L. (2010). Cerebrolysin adjuvant treatment in Broca’s aphasics following first acute ischemic stroke of the left middle cerebral artery. Journal of Medicine and Life, 3(3), 297–307.
- Jordan, L. C., & Hillis, A. E. (2006). Disorders of speech and language: Aphasia, apraxia and dysarthria. Current Opinion in Neurology, 19(6), 580–585. https://doi.org/10.1097/WCO.0b013e3280109260
- Jorge, R. E., Acion, L., Moser, D., Adams, H. P., Jr, & Robinson, R. G. (2010). Escitalopram and enhancement of cognitive recovery following stroke. Archives of General Psychiatry, 67(2), 187–196. https://doi.org/10.1001/archgenpsychiatry.2009.185
- Jung, J., Williams, S. R., Sanaei Nezhad, F., & Lambon Ralph, M. A. (2017). GABA concentrations in the anterior temporal lobe predict human semantic processing. Scientific Reports, 7(1), 15748. https://doi.org/10.1038/s41598-017-15981-7
- Kendall, D. L., Moldestad, M. O., Allen, W., Torrence, J., & Nadeau, S. E. (2019). Phonomotor versus semantic feature analysis treatment for anomia in 58 persons with aphasia: A randomized controlled trial. Journal of Speech Language and Hearing Research, 62(12), 4464–4482. https://doi.org/10.1044/2019_JSLHR-L-18-0257
- Keser, Z., Dehgan, M. W., Shadravan, S., Yozbatiran, N., Maher, L. M., & Francisco, G. E. (2017). Combined dextroamphetamine and transcranial direct current stimulation in poststroke aphasia. American Journal of Physical Medicine and Rehabilitation, 96(10 Suppl 1), S141–S145. https://doi.org/10.1097/PHM.0000000000000780
- Kessler, J., Thiel, A., Karbe, H., & Heiss, W. D. (2000). Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke, 31(9), 2112–2116. https://doi.org/10.1161/01.STR.31.9.2112
- Kilgard, M. P., & Merzenich, M. M. (1998). Cortical map reorganization enabled by nucleus basalis activity. Science, 279(5357), 1714–1718. https://doi.org/10.1126/science.279.5357.1714
- Kiran, S., & Thompson, C. K. (2019). Neuroplasticity of language networks in aphasia: Advances, updates, and future challenges. Frontiers in Neurology, 10, 295. https://doi.org/10.3389/fneur.2019.00295
- Kleim, J. A., & Jones, T. A. (2008). Principles of experience-dependent neural plasticity: Implications for rehabilitation after brain damage. Journal of Speech, Language, and Hearing Research, 51(1), S225–S239. https://doi.org/10.1044/1092-4388(2008/018)
- Knecht, S., Breitenstein, C., Bushuven, S., Wailke, S., Kamping, S., Flöel, A., Zwitserlood, P., & Ringelstein, E. B. (2004). Levodopa: Faster and better word learning in normal humans. Annals of Neurology, 56(1), 20–26. https://doi.org/10.1002/ana.20125
- Kohn, S. E., Smith, K. L., & Alexander, M. P. (1996). Differential recovery from impairment to the phonological lexicon. Brain and Language, 52(1), 129–149. https://doi.org/10.1006/brln.1996.0007
- Krakauer, J. W., & Carmichael, S. T. (2017). Pharmacological and cell therapies for recovery from stroke. In J. W. Krakauer & S.T. Carmichael (Eds.), Broken movement. The neurobiology of motor recovery after stroke (pp. 185–208). The MIT Press. Chapter 7.
- Kurdziel, L. B. F., Mantua, J., & Spencer, R. M. C. (2017). Novel word learning in older adults: A role for sleep? Brain and Language, 167, 106–113. https://doi.org/10.1016/j.bandl.2016.05.010
- Laine, M., & Martin, N. (2006). Brain Damage, Behaviour, and Cognition Series. Anomia. Theoretical and Clinical Aspects. UK: Psychology Press.
- Lam, J. M., & Wodchis, W. P. (2010). The relationship of 60 disease diagnoses and 15 conditions to preference-based health-related quality of life in Ontario hospital-based long-term care residents. Medical Care, 48(4), 380–387. https://doi.org/10.1097/MLR.0b013e3181ca2647
- Lambon Ralph, M. A., Patterson, K., & Plaut, D. C. (2011). Finite case series or infinite single-case studies? Comments on “case series investigations in cognitive neuropsychology” by Schwartz and Dell (2010). Cognitive Neuropsychology, 28(7), 466–474. https://doi.org/10.1080/02643294.2012.671765
- Lambon Ralph, M. A., Snell, C., Fillingham, J. K., Conroy, P., & Sage, K. (2010). Predicting the outcome of anomia therapy for people with aphasia post CVA: Both language and cognitive status are key predictors. Neuropsychological Rehabilitation, 20(2), 289–305. https://doi.org/10.1080/09602010903237875
- Larsson, D., Åsberg, S., Kumlien, E., & Zelano, J. (2019). Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study. Seizure, 64, 29–33. https://doi.org/10.1016/j.seizure.2018.11.013
- Laska, A.C, von Arbin, M, Kahan, T, Hellblom, A, & Murray, V. (2005). Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovascular Diseases, 19(2), 125-132. doi:10.1159/0000083256
- Leemann, B., Laganaro, M., Chetelat-Mabillard, D., & Schnider, A. (2011). Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo. Neurorehabilitation and Neural Repair, 25(1), 43–47. https://doi.org/10.1177/1545968310376938
- Leiguarda, R., Merello, M., Sabe, L., & Starkstein, S. (1993). Bromocriptine-induced dystonia in patients with aphasia and hemiparesis. Neurology, 43(11), 2319–2322. https://doi.org/10.1212/WNL.43.11.2319
- Llano, D. A., & Small, S. L. (2016). Pharmacotherapy for aphasia. In G. Hickok & S. L. Small (Eds.), Neurobiology of Language (pp. 1067–1083). Academic Press. Chapter 85.
- López-Barroso, D., & de Diego-balaguer, R. (2017). Language learning variability within the dorsal and ventral streams as a cue for compensatory mechanisms in aphasia recovery. Frontiers in Human Neuroscience, 11, 476. https://doi.org/10.3389/fnhum.2017.00476
- López-Barroso, D., Torres-Prioris, M. J., Beltrán-Corbellini, A., Dávila, G., Edelkraut, L., & Berthier, M. (2018). Beneficial effects of pharmacological treatment in post-stroke dynamic aphasia: A behavioural and neuroimaging study. European Workshop for Cognitive Neuropsychology.
- Luria, A. R. (1963). Restoration of function after brain injury. Macmillan.
- Ma, H. M., & Zafonte, R. D. (2020). Amantadine and memantine: A comprehensive review for acquired brain injury. Brain Injury, 34(3), 299-315. doi:10.1080/02699052.1723697
- Mason, C., Nickels, L., & McDonald, B. (2020). An exploration of the impact of group treatment for aphasia on connected speech. Journal of the International Neuropsychological Society, 26(1), 72–85. https://doi.org/10.1017/S1355617719001012
- McClung, J. S., Rothi, L. J., & Nadeau, S. E. (2010). Ambient experience in restitutive treatment of aphasia. Frontiers in Human Neuroscience, 4,183. doi:10.3389/fnhum.2010.00183
- McNamara, P., & Albert, M. L. (2004). Neuropharmacology of verbal perseveration. Seminars in Speech and Language, 25(4), 309–321. https://doi.org/10.1055/s-2004-837244
- McNeil, M. R., Doyle, P. J., Spencer, K. A., Jackson, G.A., Flores, D., & Small, S. L. (1997). A double-blind, placebo-controlled study of pharmacological and behavioral treatment of lexical-semantic deficits in aphasia. Aphasiology, 11(4/5), 358–400. https://doi.org/10.1080/02687039708248479
- Mead, G., Hackett, M. L., Lundström, E., Murray, V., Hankey, G. J., & Dennis, M. (2015). The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: A study protocol for three multicentre randomised controlled trials. Trials, 16(1), 369. https://doi.org/10.1186/s13063-015-0864-1
- Mead, G. E., Hsieh, C.-F, Lee, R., Kutlubaev, M., Claxton, A., Hankey, G. J., … Hackett, M. (2013). Selective serotonin reuptake inhibitors for stroke recovery: A systematic review and meta-analysis. Stroke, 44(3), 844–850. https://doi.org/10.1161/STROKEAHA.112.673947
- Meinzer, M., Darkow, R., Lindenberg, R., & Flöel, A. (2016). Electrical stimulation of the motor cortex enhances treatment outcome in post-stroke aphasia. Brain, 139(4), 1152–1163. https://doi.org/10.1093/brain/aww002
- Meinzer, M., Mohammadi, S., Kugel, H., Schiffbauer, H., Flöel, A., Albers, J., Kramer, K., Menke, R., Baumgärtner, A., Knecht, S., Breitenstein, C., & Deppe, M. (2010). Integrity of the hippocampus and surrounding white matter is correlated with language training success in aphasia. Neuroimage, 53(1), 283–290. https://doi.org/10.1016/j.neuroimage.2010.06.004
- Mena-Segovia, J., & Bolam, J. P. (2017). Rethinking the pedunculopontine nucleus: From cellular organization to function. Neuron, 94(1), 7–18. https://doi.org/10.1016/j.neuron.2017.02.027
- Menichelli, A., Furlanis, G., Sartori, A., Ridolfi, M., Naccarato, M., Caruso, P., Pesavento, V., & Manganotti, P. (2019). Thrombolysis’ benefits on early post-stroke language recovery in aphasia patients. Journal of Clinical Neuroscience, 70, 92–95. https://doi.org/10.1016/j.jocn.2019.08.064
- Menke, R., Meinzer, M., Kugel, H., Deppe, M., Baumgärtner, A., Schiffbauer, H., Thomas, M., Kramer, K., Lohmann, H., Flöel, A., Knecht, S., & Breitenstein, C. (2009). Imaging short- and long-term training success in chronic aphasia. BMC Neuroscience, 10(1), 118. https://doi.org/10.1186/1471-2202-10-118
- Meschia, J. F., McNeil, R. B., Barrett, K. M., Brott, T. G., Graff-Radford, N. R., & Brown, R. D. (2010). Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) protocol. Journal of Stroke and Cerebrovascular Diseases, 19(4), 299–310. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.05.005
- Mesulam, M. M. (2013). Cholinergic circuitry of the human nucleus basalis and its fate in alzheimer’s disease. Journal of Comparative Neurology, 521(18), 4124–4144. https://doi.org/10.1002/cne.23415
- Mohr, B., Stahl, B., Berthier, M. L., & Pulvermüller, F. (2017). Intensive communicative therapy reduces symptoms of depression in chronic nonfluent aphasia. Neurorehabilitation and Neural Repair, 31(12), 1053–1062. https://doi.org/10.1177/1545968317744275
- Morosan, P., Schleicher, A., Amunts, K., & Zilles, K. (2005). Multimodal architectonic mapping of human superior temporal gyrus. Anatomy and Embryology (Berlin), 210(5–6), 401–406. https://doi.org/10.1007/s00429-005-0029-1
- Mula, M., Trimble, M. R., Thompson, P., & Sander, J. W. (2003). Topiramate and word-finding difficulties in patients with epilepsy. Neurology, 60(7), 1104–1107. https://doi.org/10.1212/01.WNL.0000056637.37509.C6
- Nadeau, S. E., Lu, X., Dobkin, B., Wu, S. S., Dai, Y. E., Duncan, P. W., & LEAPS Investigative Team (2014). A prospective test of the late effects of potentially antineuroplastic drugs in a stroke rehabilitation study. International Journal of Stroke, 9(4), 449–456. https://doi.org/10.1111/j.1747-4949.2012.00920.x
- Nadeau, S. E., Wu, S. S., Taub, E., & Uswatte, G. (2006). CIMT as a behavioral engine in research on physiological adjuvants to neurorehabilitation: The challenge of merging animal and human research. NeuroRehabilitation, 21(2), 107–130. https://doi.org/10.3233/NRE-2006-21203
- Nickels, L. (2002). Therapy for naming disorders: Revisiting, revising, and reviewing. Aphasiology, 16(10/11), 935–979. https://doi.org/10.1080/02687030244000563
- Nickels, L., McDonald, B., Mason, C., & Parente, R. (2016). The impact of group therapy on word retrieval in people with chronic aphasia. NeuroRehabilitation, 39(1), 81–95. https://doi.org/10.3233/NRE-161340
- Noppeney, U., Friston, K. J., & Price, C. J. (2004). Degenerate neuronal systems sustaining cognitive functions. Journal of Anatomy, 205(6), 433–442. https://doi.org/10.1111/j.0021-8782.2004.00343.x
- Orgogozo, J.-M. (1999). Piracetam in the treatment of acute stroke. Pharmacopsychiatry, 32(Suppl S 1), 25–32. https://doi.org/10.1055/s-2007-979233
- Paolucci, S. (2017). Advances in antidepressants for treating post-stroke depression. Expert Opinion in Pharmacotherapy, 18(10), 1011–1017. https://doi.org/10.1080/14656566.2017.1334765
- Pulvermüller, F., & Berthier, M. L. (2008). Aphasia therapy on a neuroscience basis. Aphasiology, 22(6), 563–599. https://doi.org/10.1080/02687030701612213
- Robinson, R. G., Jorge, R. E., Moser, D. J., Acion, L., Solodkin, A., Small, S. L., Fonzetti, P., Hegel, M., & Arndt, S. (2008). Escitalopram and problem-solving therapy for prevention of poststroke depression: A randomized controlled trial. JAMA, 299(20), 2391–2400. https://doi.org/10.1001/jama.299.20.2391
- Robson, H., Specht, K., Beaumont, H., Parkes, L. M., Sage, K., Lambon Ralph, M. A., … Zahn, R. (2017). Arterial spin labelling shows functional depression of non-lesion tissue in chronic Wernicke’s aphasia. Cortex, 92, 249–260. https://doi.org/10.1016/j.cortex.2016.11.002
- Robson, H., Zahn, R., Keidel, J. L., Binney, R. J., Sage, K., & Lambon Ralph, M. A. (2014). The anterior temporal lobes support residual comprehension in Wernicke’s aphasia. Brain, 137(3), 931–943. https://doi.org/10.1093/brain/awt373
- Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., & Friedhoff, L. T. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Donepezil Study Group. Neurology, 50(1), 136–145. https://doi.org/10.1212/WNL.50.1.136
- Rösler, M., Anand, R., Cicin-Sain, A., Gauthier, S., Agid, Y., Dal-Bianco, P., Hartman, R., Gharabawi, M., Bayer, T., & Stahelin, H. B. (1999). Efficacy and safety of rivastigmine in patients with Alzheimer’s’s disease: International randomised controlled trial commentary: Another piece of the Alzheimer’s jigsaw. BMJ (Clinical Research Ed), 318(7184), 633–638. https://doi.org/10.1136/bmj.318.7184.633
- Sabe, L., Salvarezza, F., García Cuerva, A., Leiguarda, R., & Starkstein, S. (1995). A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology, 45(12), 2272–2274. https://doi.org/10.1212/WNL.45.12.2272
- Saper, C. B., & Fuller, P. M. (2017). Wake–sleep circuitry: An overview. Current Opinion in Neurobiology, 44, 186–192. https://doi.org/10.1016/j.conb.2017.03.021
- Sarasso, S., Määttä, S., Ferrarelli, F., Poryazova, R., Tononi, G., & Small, S. L. (2014). Plastic changes following imitation-based speech and language therapy for aphasia: A high-density sleep EEG study. Neurorehabilitation and Neural Repair, 28(2), 129–138. https://doi.org/10.1177/1545968313498651
- Sarter, M., & Bruno, J. P. (2000). Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience, 95(4), 933–952. https://doi.org/10.1016/S0306-4522(99)00487-X
- Saxena, S., & Hillis, A. E. (2017). An update on medications and noninvasive brain stimulation to augment language rehabilitation in post-stroke aphasia. Expert Review in Neurotherapeutics, 17(11), 1091–1107. https://doi.org/10.1080/14737175.2017.1373020
- Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., & Kivipelto, M. (2014). Clinical trials and late-stage drug development for Alzheimer’s disease: An appraisal from 1984 to 2014. Journal of Internal Medicine, 275(3), 251–283. https://doi.org/10.1111/joim.12191
- Schomers, M. R., Garagnani, M., & Pulvermüller, F. (2017). Neurocomputational consequences of evolutionary connectivity changes in perisylvian language cortex. Journal of Neuroscience, 11(4–5), 3045–3055. https://doi.org/10.1523/JNEUROSCI.2693-16.2017
- Schumacher, R., Halai, A. D., & Lambon Ralph, M. A. (2019). Assessing and mapping language, attention and executive multidimensional deficits in stroke aphasia. Brain, 142(10), 3202–3216. https://doi.org/10.1093/brain/awz258
- Seniów, J., Litwin, M., Litwin, T., Leśniak, M., & Członkowska, A. (2009). New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. Journal of Neurological Sciences, 283(1–2), 214–218. https://doi.org/10.1016/j.jns.2009.02.336
- Shallice, T., & Buiatti, T. (2011). Types of case series—the anatomically based approach: Commentary on M. F. Schwartz & G. S. Dell: Case series investigations in cognitive neuropsychology. Cognitive Neuropsychology, 28(7), 500–514. https://doi.org/10.1080/02643294.2012.674012
- Shellshear, L., MacDonald, A. D., Mahoney, J., Finch, E., McMahon, K., Silburn, P., Nathan, P. J., & Copland, D. A. (2015). Levodopa enhances explicit new-word learning in healthy adults: A preliminary study. Human Psychopharmacology: Clinical and Experimental, 30(5), 341–349. https://doi.org/10.1002/hup.2480
- Shisler, R. J., Baylis, G. C., & Frank, E. M. (2000). Pharmacological approaches to the treatment and prevention of aphasia. Aphasiology, 14(12), 1163–1186. https://doi.org/10.1080/02687030050205705
- Smania, N., Gandolfi, M, Aglioti, S. M., Girardi, P., Fiaschi, A., & Girardi, F. (2010). How long is the recovery of global aphasia? Twenty-five years of follow-up in a patient with left hemisphere stroke. Neurorehabilitation and Neural Repair, 24(9), 871-875.
- Sparks, R., Helm, N., & Albert, M. (1974). Aphasia rehabilitation resulting from melodic intonation therapy. Cortex, 10(4), 303–316. https://doi.org/10.1016/S0010-9452(74)80024-9
- Staekenborg, S. S., van der Flier, W. M., van Straaten, E. C., Lane, R., Barkhof, F., & Scheltens, P. (2008). Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke, 39(2), 317–322. https://doi.org/10.1161/STROKEAHA.107.493353
- Stahl, B., Darkow, R., von Podewils, V., Meinzer, M., Grittner, U., Reinhold, T., Flöel, A., Grewe, T., & Breitenstein, C. (2019). Transcranial direct current stimulation to enhance training effectiveness in chronic post-stroke aphasia: A randomized controlled trial protocol. Frontiers in Neurology, 10, 1089. https://doi.org/10.3389/fneur.2019.01089
- Stahl, B., Mohr, B., Dreyer, F. R., Lucchese, G., & Pulvermüller, F. (2016). Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia. Cortex, 85, 90–99. https://doi.org/10.1016/j.cortex.2016.09.021
- Stefaniak, J. D., Halai, A. D., & Lambon Ralph, M. A. (2020). The neural and neurocomputational bases of recovery from post-stroke aphasia. Nature Reviews. Neurology, 16(1), 43–55. https://doi.org/10.1038/s41582-019-0282-1
- Stewart, J. C., & Cramer, S. C. (2017). Genetic variation and neuroplasticity: Role in rehabilitation after stroke. Journal of Neurological Physical Therapy, 41(Suppl 3), S17–S23. https://doi.org/10.1097/NPT.0000000000000180
- Tamminen, J., Lambon Ralph, M. A., & Lewis, P. A. (2013). The role of sleep spindles and slow-wave activity in integrating new information in semantic memory. Journal of Neurosciences, 33(39), 15376–15381. doi:10.1016/j.nlm.2016.11012
- Tan, L. C., Ng, K. K., Au, W. L., Lee, R. K., Chan, Y. H., & Tan, N. C. (2009). Bromocriptine use and the risk of valvular heart disease. Movement Disorders, 24(3), 344–349. https://doi.org/10.1002/mds.22228
- Tanaka, Y., Albert, M. L., Fujita, K., Nonaka, C., & Yokoyama, E. (2006). Treating perseveration improves naming in aphasia. Brain and Language, 99(1–2), 57–58. https://doi.org/10.1016/j.bandl.2006.06.038
- Tocco, M., Bayles, K., Lopez, O. L., Hofbauer, R. K., Pejoviċ, V., Miller, M. L., … Saxton, J. (2014). Effects of memantine treatment on language abilities and functional communication: A review of data. Aphasiology, 28(2), 236–257. https://doi.org/10.1080/02687038.2013.838617
- Torres-Prioris, M. J., López-Barroso, D., Paredes-Pacheco, J., Roé-Vellvé, N., Dawid-Milner, M. S., & Berthier, M. L. (2019). Language as a threat: Multimodal evaluation and interventions for overwhelming linguistic anxiety in severe aphasia. Frontiers in Psychology, 10, 678. https://doi.org/10.3389/fpsyg.2019.00678
- Torres-Prioris, M. J., López-Barroso, D., Roé-Vellvé, N., Paredes-Pacheco, J., Dávila, G., & Berthier, M. L. (2019). Repetitive verbal behaviors are not always harmful signs: Compensatory plasticity within the language network in aphasia. Brain and Language, 190, 16–30. https://doi.org/10.1016/j.bandl.2018.12.004
- Tsikunov, S. G., & Belokoskova, S. G. (2007). Psychophysiological analysis of the influence of vasopressin on speech in patients with post-stroke aphasias. The Spanish Journal of Psychology, 10(1), 178–188. https://doi.org/10.1017/S1138741600006442
- Walker-Batson, D., Curtis, S., Natarajan, R., Ford, J., Dronkers, N., Salmeron, E., Lai, J., & Unwin, D. H. (2001). A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke, 32(9), 2093–2098. https://doi.org/10.1161/hs0901.095720
- Walker-Batson, D., Mehta, J., Smith, P., & Johnson, M. (2016). Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke. Progress in Neuropsychopharmacology and Biological Psychiatry, 64, 225–230. https://doi.org/10.1016/j.pnpbp.2015.04.002
- Wandschneider, B., Burdett, J., Townsend, L., Hill, A., Thompson, P. J., Duncan, J. S., … Koepp, M. J. (2017). Effect of topiramate and zonisamide on fMRI cognitive networks. Neurology, 88(12), 1165–1171. https://doi.org/10.1212/WNL.0000000000003736
- Wandschneider, B., & Koepp, M. J. (2016). Pharmaco fMRI: Determining the functional anatomy of the effects of medication. Neuroimage Clinical, 12, 691–697. https://doi.org/10.1016/j.nicl.2016.10.002
- Whiting, E., Chenery, H. J., Chalk, J., & Copland, D. A. (2007). Dexamphetamine boosts naming treatment effects in chronic aphasia. Journal of the International Neuropsychological Society, 13(6), 972–979. https://doi.org/10.1017/S1355617707071317
- Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000). Efficacy and safety of galantamine in patients with mild to moderate alzheimer’s disease: Multicentre randomised controlled trial. Galantamine International-1 Study Group. BMJ, 321(7274), 1445–1449. https://doi.org/10.1136/bmj.321.7274.1445
- Wilmskoetter, J., Marebwa, B., Basilakos, A., Fridriksson, J., Rorden, C., Stark, B. C., Johnson, L., Hickok, G., Hillis, A. E., & Bonilha, L. (2019). Long-range fibre damage in small vessel brain disease affects aphasia severity. Brain, 142(10), 3190–3201. https://doi.org/10.1093/brain/awz251
- Wirsich, J., Rey, M., Guye, M., Bénar, C., Lanteaume, L., Ridley, B., Confort-Gouny, S., Cassé-Perrot, C., Soulier, E., Viout, P., Rouby, F., Lefebvre, M.-N., Audebert, C., Truillet, R., Jouve, E., Payoux, P., Bartrés-Faz, D., Bordet, R., Richardson, J. C., Babiloni, C., & Ranjeva, J.-P., & Pharmacog Consortium. (2018). Brain networks are independently modulated by donepezil, sleep, and sleep deprivation. Brain Topography, 31(3), 380–391. https://doi.org/10.1007/s10548-017-0608-5
- Woodhead, Z. V., Crinion, J., Teki, S., Penny, W., Price, C. J., & Leff, A. P. (2017). Auditory training changes temporal lobe connectivity in ‘Wernicke’s aphasia’: A randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry, 88(7), 586–594. https://doi.org/10.1136/jnnp-2016-314621
- Wray, F., & Clarke, D. (2017). Longer-term needs of stroke survivors with communication difficulties living in the community: A systematic review and thematic synthesis of qualitative studies. BMJ Open, 7(10), e017944. https://doi.org/10.1136/bmjopen-2017-017944
- Yagata, S. A., Yen, M., McCarron, A., Bautista, A., Lamair-Orosco, G., & Wilson, S. M. (2017). Rapid recovery from aphasia after infarction of Wernicke’s area. Aphasiology, 31(8), 951–980. https://doi.org/10.1080/02687038.2016.1225276
- Yoon, S. Y., Kim, J.-K, An, Y.-S, & Kim, Y. W. (2015). Effect of donepezil on Wernicke aphasia after bilateral middle cerebral artery infarction: Subtraction analysis of brain F-18 fluorodeoxyglucose positron emission tomographic images. Clinical Neuropharmacology, 38(4), 147–150. https://doi.org/10.1097/WNF.0000000000000089
- Zelano, J. (2016). Poststroke epilepsy: Update and future directions. Therapeutic Advances in Neurological Disorders, 9(5), 424–435. https://doi.org/10.1177/1756285616654423
- Zhang, J., Wei, R., Chen, Z., & Luo, B. (2016). Piracetam for aphasia in post-stroke patients: A systematic review and meta-analysis of randomized controlled trials. CNS Drugs, 30(7), 575–587. https://doi.org/10.1007/s40263-016-0348-1
- Zhang, X., Shu, B., Zhang, D., Huang, L., Fu, Q., & Du, G. (2018). The efficacy and safety of pharmacological treatments for post-stroke aphasia. CNS & Neurological Disorders Drug Targets, 17(7), 509–521. https://doi.org/10.2174/1871527317666180706143051